发布求助

文献互助智能选刊最新文献

Global & Regional Health Technology Assessment

查看最新文献

3842

WOS期刊分区历年影响因子历年发表同类期刊

影响因子：

0.4

ISSN：

print: 2284-2403
on-line: 2283-5733

研究领域：

HEALTH CARE SCIENCES & SERVICES

自引率：

20.00%

Gold OA文章占比：

100.00%

原创研究文献占比：

100.00%

SCI收录类型：

Emerging Sources Citation Index (ESCI) || Directory of Open Access Journals (DOAJ)

期刊官网：

https://journals.aboutscience.eu/index.php/grhta/index

期刊介绍英文：

Global & Regional Health Technology Assessment (GRHTA) is a peer-reviewed, open access journal which aims to promote health technology assessment and economic evaluation, enabling choices among alternative therapeutical paths or procedures with different clinical and economic outcomes. GRHTA is a unique journal having three different editorial boards who focus on their respective geographical expertise.

CiteScore：

CiteScore	SJR	SNIP	CiteScore排名
0.8		0.292	学科排名百分位大类：Medicine 小类：Medicine (miscellaneous) 284 / 398 28% 大类：Medicine 小类：Health Policy 246 / 310 20% 大类：Medicine 小类：Public Health, Environmental and Occupational Health 545 / 665 18%

发文信息

WOS期刊分区

学科分类
Q4HEALTH CARE SCIENCES & SERVICES

历年影响因子

2022年	0.5000
2023年	0.4000

历年发表

2014年	9
2015年	31
2016年	47
2017年	31
2018年	26
2019年	21
2020年	20
2021年	23
2022年	27

投稿信息

出版语言：

English, Spanish, Italian

出版国家(地区)：

Italy

审稿时长：

8 weeks

出版商：

AboutScience Srl

PubMed链接：

http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2284-2403%5BISSN%5D

Global & Regional Health Technology Assessment - 最新文献

Analisi di costo-efficacia di brentuximab vedotin in combinazione con doxorubicina, vinblastina e dacarbazina (AVD) in pazienti adulti affetti da linfoma di Hodgkin in stadio IV.

Pub Date : 2024-12-10 DOI: 10.33393/grhta.2024.3167 Andrea Marcellusi, Chiara Bini, Francesco Saverio Mennini, Silvia Ripoli, Laura Fioravanti, Victoria Federico Paly, Alexa Lina Molinari, Paolo Morelli, Stanimira Krotneva, Shujun Li

A 1-year per-patient cost of therapy administration analysis of mosunetuzumab and tisagenlecleucel in relapsed or refractory follicular lymphoma patients receiving two or more lines of systemic therapy.

Pub Date : 2024-12-09 DOI: 10.33393/grhta.2024.3170 Marco Bellone, Alice Sabinot, Alessandro D'Arpino, Emanuela Omodeo Salè, Daniela Ghislieri, Lorenzo Pradelli

Impatto economico di dapagliflozin nella gestione della malattia renale cronica in Italia: risultati di un modello di micro-simulazione.

Pub Date : 2024-12-02 DOI: 10.33393/grhta.2024.3309 Roberto Ravasio, Andrea Marcellusi, Luca de Nicola

查看全部

免责声明：
本页显示期刊或杂志信息，仅供参考学习，不是任何期刊杂志官网，不涉及出版事务，特此申明。如需出版一切事务需要用户自己向出版商联系核实。若本页展示内容有任何问题，请联系我们，邮箱：info@booksci.cn，我们会认真核实处理。